CASP8AP2 and cancer: Our observation that loss of FLASH and gemcitabine treatment synergized to promote PANC-1 cell death suggests that FLASH employs multiple mechanisms to promote cancer cell survival: (1) as a pro-survival factor and (2) as a chemoresistance factor.